119 related articles for article (PubMed ID: 38085828)
1. Integrative Multianalytical Model Based on Novel Plasma Protein Biomarkers for Distinguishing Lung Adenocarcinoma and Benign Pulmonary Nodules.
Zhang X; Ji L; Liu M; Li J; Sun H; Liang F; Zhao Y; Wang Z; Yang T; Wang Y; Si Q; Du R; Dai L; Ouyang S
J Proteome Res; 2024 Jan; 23(1):277-288. PubMed ID: 38085828
[TBL] [Abstract][Full Text] [Related]
2. Combined detection of serum IL-6 and CEA contributes to the diagnosis of lung adenocarcinoma
Pan J; Zhuang W; Xia Y; Huang Z; Zheng Y; Wang X; Huang Y
PeerJ; 2024; 12():e17141. PubMed ID: 38529301
[TBL] [Abstract][Full Text] [Related]
3. CT and CEA-based machine learning model for predicting malignant pulmonary nodules.
Liu M; Zhou Z; Liu F; Wang M; Wang Y; Gao M; Sun H; Zhang X; Yang T; Ji L; Li J; Si Q; Dai L; Ouyang S
Cancer Sci; 2022 Dec; 113(12):4363-4373. PubMed ID: 36056603
[TBL] [Abstract][Full Text] [Related]
4. A Diagnostic Model With IgM Autoantibodies and Carcinoembryonic Antigen for Early Detection of Lung Adenocarcinoma.
Zhang X; Li J; Wang Y; Liu M; Liu F; Zhang X; Pei L; Wang T; Jiang D; Wang X; Zhang J; Dai L
Front Immunol; 2021; 12():728853. PubMed ID: 35140701
[TBL] [Abstract][Full Text] [Related]
5. A Noninvasive Multianalytical Approach for Lung Cancer Diagnosis of Patients with Pulmonary Nodules.
Liu QX; Zhou D; Han TC; Lu X; Hou B; Li MY; Yang GX; Li QY; Pei ZH; Hong YY; Zhang YX; Chen WZ; Zheng H; He J; Dai JG
Adv Sci (Weinh); 2021 Jul; 8(13):2100104. PubMed ID: 34258160
[TBL] [Abstract][Full Text] [Related]
6. Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma.
Gao S; Guo W; Liu T; Liang N; Ma Q; Gao Y; Tan F; Xue Q; He J
Cancer Sci; 2022 Feb; 113(2):648-659. PubMed ID: 34837453
[TBL] [Abstract][Full Text] [Related]
7. CT-Assisted Improvements in the Accuracy of the Intraoperative Frozen Section Examination of Ground-Glass Density Nodules.
Xinli W; Xiaoshuang S; Chengxin Y; Qiang Z
Comput Math Methods Med; 2022; 2022():8967643. PubMed ID: 35035526
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial.
Silvestri GA; Tanner NT; Kearney P; Vachani A; Massion PP; Porter A; Springmeyer SC; Fang KC; Midthun D; Mazzone PJ;
Chest; 2018 Sep; 154(3):491-500. PubMed ID: 29496499
[TBL] [Abstract][Full Text] [Related]
9. Humoral immune response to tumor-associated antigen Ubiquilin 1 (UBQLN1) and its tumor-promoting potential in lung cancer.
Wang Y; Ouyang S; Liu M; Si Q; Zhang X; Zhang X; Li J; Wang P; Ye H; Shi J; Song C; Wang K; Dai L
BMC Cancer; 2024 Mar; 24(1):283. PubMed ID: 38431566
[TBL] [Abstract][Full Text] [Related]
10. Metabolomic differentiation of benign vs malignant pulmonary nodules with high specificity via high-resolution mass spectrometry analysis of patient sera.
Yao Y; Wang X; Guan J; Xie C; Zhang H; Yang J; Luo Y; Chen L; Zhao M; Huo B; Yu T; Lu W; Liu Q; Du H; Liu Y; Huang P; Luan T; Liu W; Hu Y
Nat Commun; 2023 Apr; 14(1):2339. PubMed ID: 37095081
[TBL] [Abstract][Full Text] [Related]
11. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
Li X; Zhang Q; Jin X; Cao L
World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
[TBL] [Abstract][Full Text] [Related]
12. Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma.
Li J; Li J; Hao H; Lu F; Wang J; Ma M; Jia B; Zhuo M; Wang J; Chi Y; Zhai X; Wang Y; Wu M; An T; Zhao J; Yang F; Wang Z
BMC Cancer; 2023 Jan; 23(1):110. PubMed ID: 36721112
[TBL] [Abstract][Full Text] [Related]
13. Integration of bioinformatics analysis and experimental validation identifies plasma exosomal miR-103b/877-5p/29c-5p as diagnostic biomarkers for early lung adenocarcinoma.
Wu J; Feng Z; Wang R; Li A; Wang H; He X; Shen Z
Cancer Med; 2022 Dec; 11(23):4411-4421. PubMed ID: 35585716
[TBL] [Abstract][Full Text] [Related]
14. [Establishment and Verification of A Novel Predictive Model of Malignancy
for Non-solid Pulmonary Nodules].
Xiao F; Yu Q; Zhang Z; Liu D; Liang C
Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):26-33. PubMed ID: 30674390
[TBL] [Abstract][Full Text] [Related]
15. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
[TBL] [Abstract][Full Text] [Related]
16. Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
Wang J; Shivakumar S; Barker K; Tang Y; Wallstrom G; Park JG; Tsay JC; Pass HI; Rom WN; LaBaer J; Qiu J
J Thorac Oncol; 2016 Mar; 11(3):334-45. PubMed ID: 26896032
[TBL] [Abstract][Full Text] [Related]
17. Plasma Exosomal CXCL7 is a Potential Biomarker for Lung Adenocarcinoma.
Fang W; You J; Xu Q; Jiang Y; Hu H; Chen F; Chen L
Clin Lab; 2022 Oct; 68(10):. PubMed ID: 36250818
[TBL] [Abstract][Full Text] [Related]
18. Preoperative CT-based radiomics combined with intraoperative frozen section is predictive of invasive adenocarcinoma in pulmonary nodules: a multicenter study.
Wu G; Woodruff HC; Sanduleanu S; Refaee T; Jochems A; Leijenaar R; Gietema H; Shen J; Wang R; Xiong J; Bian J; Wu J; Lambin P
Eur Radiol; 2020 May; 30(5):2680-2691. PubMed ID: 32006165
[TBL] [Abstract][Full Text] [Related]
19. [Multivariate Analysis of Solid Pulmonary Nodules Smaller than 1 cm in
Distinguishing Lung Cancer from Intrapulmonary Lymph Nodes].
Tang J; Liu C; Wang P; Cui Y
Zhongguo Fei Ai Za Zhi; 2021 Feb; 24(2):94-98. PubMed ID: 33508896
[TBL] [Abstract][Full Text] [Related]
20. [Clinical Study of Artificial Intelligence-assisted Diagnosis System in Predicting the
Invasive Subtypes of Early-stage Lung Adenocarcinoma Appearing as Pulmonary Nodules].
Su Z; Mao W; Li B; Zheng Z; Yang B; Ren M; Song T; Feng H; Meng Y
Zhongguo Fei Ai Za Zhi; 2022 Apr; 25(4):245-252. PubMed ID: 35477188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
